Veterinary Diagnostics

To place an order, please choose your country

Subscribe newsletter

SARS-CoV-2 / Covid-19



In vitro Diagnostic Medical Device for the detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in humans

This kit allows for the specific amplification of four target sequences:

  • Three target sequences of SARS-CoV-2 viral RNA: one sequence on the N gene and two sequences on the RdRP gene
  • A sequence for endogenous internal control

Test based on RT-qPCR technology, useable as a first-intention test, from nasopharyngeal swabs.

Kit in ready-to-use format.  

Can be used in combination with the DI SARS-CoV-2 MOC/I Multiplex to screen SARS-CoV-2 mutations of concern and interest.

For in vitro diagnostic use, CE-IVD marked kit.





  • CE-IVD marked kit referenced on the French Covid-19 platform Ministry of Solidarity and Health:  

  • Flexible protocols: 
    • Direct PCR without prior extraction shortening the overall analysis time 
    • PCR from extracted RNA 
  • Fast and simple set-up: ready-to-use reagents, results in 1 hour 
  • High specificity: primers and probes based on CDC (USA) and the Institut Pasteur (France) publications 
  • High sensitivity: PCR limit of detection of 1.25 copies/µL 
  • Reliability:  
    • Detection of an endogenous internal control to ensure the validity of the analysis 
    • High diagnostic sensitivity and specificity 
  • Thermocycler reproducibility: performance validated on QuantStudio5™, LightCycler®96 System and CFX Opus 96 Real-time PCR Instrument 

Method :

RT-qPCR - Duplex - Qualitative

Target gene :

N1, RdRP and GAPDH

Sample types :

Nasopharyngeal swabs

Protocol :

Duration approx. 1h

Thermocyclers :

QuantStudio 5™ (Applied Biosystems), LightCycler® 96 System (Roche) and CFX OPUS 96 Real-Time PCR Instrument (BIO-RAD)

Shipping temperature :


Storage temperature :

-16°C; -26°C

Marking :


Product reference


DICOV-IRES-100 100 tests

Associated products